<?xml version="1.0" encoding="UTF-8" standalone="yes"?><article xmlns:ns2="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3"><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Med Biol Res</journal-id><journal-id journal-id-type="publisher-id">bjmbr</journal-id><journal-title-group><journal-title>Brazilian Journal of Medical and Biological Research</journal-title><abbrev-journal-title abbrev-type="publisher">Braz. J. Med. Biol. Res.</abbrev-journal-title></journal-title-group><issn pub-type="epub">1414-431X</issn><publisher><publisher-name>Associa&amp;#xe7;&amp;#xe3;o Brasileira de Divulga&amp;#xe7;&amp;#xe3;o Cient&amp;#xed;fica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="other"/><article-id pub-id-type="doi">10.1590/1414-431X20198621</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Enhancement of cellular activity in hyperglycemic mice dermal wounds dressed with chitosan-alginate membranes</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0002-7424-5233</contrib-id><name><surname>Breder</surname><given-names>J.S.C.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0001-8247-6288</contrib-id><name><surname>Pires</surname><given-names>A.L.R.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0002-1356-429X</contrib-id><name><surname>Azevedo</surname><given-names>F.F.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0002-5134-6963</contrib-id><name><surname>Apolinário</surname><given-names>P.P.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0001-7339-1581</contrib-id><name><surname>Cantaruti</surname><given-names>T.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0002-4882-0329</contrib-id><name><surname>Shahwar</surname><given-names>J.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0002-5813-332X</contrib-id><name><surname>Moraes</surname><given-names>Â.M.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0003-3149-021X</contrib-id><name><surname>Consonni</surname><given-names>S.R.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0002-7539-8477</contrib-id><name><surname>Araújo</surname><given-names>E.P.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0002-0335-2162</contrib-id><name><surname>Adams</surname><given-names>G.G.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0003-4544-6105</contrib-id><name><surname>Saad</surname><given-names>M.J.A.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0001-6521-8324</contrib-id><name><surname>Lima</surname><given-names>M.H.M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1"><label>1</label><institution content-type="orgname">Universidade Estadual de Campinas</institution><institution content-type="normalized">Universidade Estadual de Campinas</institution><institution content-type="orgdiv1">Faculdade de Enfermagem</institution><addr-line><named-content content-type="city">Campinas</named-content><named-content content-type="state">SP</named-content></addr-line><country country="Country_Code">Brasil</country><institution content-type="original">Faculdade de Enfermagem, Universidade Estadual de Campinas, Campinas, SP, Brasil</institution></aff><aff id="aff2"><label>2</label><institution content-type="orgname">Faculdade de Engenharia Química</institution><institution content-type="normalized">Faculdade de Engenharia Química</institution><institution content-type="orgdiv1">Departamento de Engenharia de Materiais e Bioprocessos</institution><addr-line><named-content content-type="state"/></addr-line><country country="Country_Code"/><institution content-type="original">Departamento de Engenharia de Materiais e Bioprocessos, Faculdade de Engenharia Química, Universidade Estadual de Campinas, Campinas, SP, Brasil</institution></aff><aff id="aff3"><label>3</label><institution content-type="orgname">University of Nottingham</institution><institution content-type="normalized">University of Nottingham</institution><institution content-type="orgdiv1">Faculty of Medicine and Health Sciences</institution><addr-line><named-content content-type="state">Nottingham</named-content></addr-line><country country="Country_Code">UK</country><institution content-type="original">Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK</institution></aff><aff id="aff4"><label>4</label><institution content-type="orgname">Instituto de Biologia</institution><institution content-type="normalized">Instituto de Biologia</institution><institution content-type="orgdiv1">Departamento de Bioquímica e Biologia Tecidual</institution><addr-line><named-content content-type="state"/></addr-line><country country="Country_Code"/><institution content-type="original">Departamento de Bioquímica e Biologia Tecidual, Instituto de Biologia, Universidade Estadual de Campinas, Campinas, SP, Brasil</institution></aff><aff id="aff5"><label>5</label><institution content-type="orgname">Faculdade de Ciências Médicas</institution><institution content-type="normalized">Faculdade de Ciências Médicas</institution><institution content-type="orgdiv1">Departamento de Clínica Médica</institution><addr-line><named-content content-type="state"/></addr-line><country country="Country_Code"/><institution content-type="original">Departamento de Clínica Médica, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brasil</institution></aff></contrib-group><author-notes><corresp>Correspondence: M.H.M. Lima: E-mail:<email>mhmelolima@gmail.com</email></corresp></author-notes><volume>52</volume><issue>10</issue><elocation-id>e8621</elocation-id><history><date date-type="received"><day>20</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2019</year></date></history><abstract><p>Running Title : Dermal wounds dressed with chitosan-alginate membranes</p></abstract><kwd-group xml:lang="en"><kwd>C57BL/6J mice</kwd><kwd>Wound healing</kwd><kwd>Wound dressing</kwd><kwd>Polysaccharides</kwd><kwd>Diabetes</kwd></kwd-group></article-meta></front><body><sec-type sec-type="intro"><title>Introduction</title><p>Wound healing is a complex process, being essentialforskin repair. It is basically comprised of three phases:inflammation, proliferation, and maturation, which overlap in time and space nullnullnull 1, 2 null. Many cell types may be involved in this process, and phenomena as the influx of macrophages, neutrophils, endothelial cells, platelets, keratinocytes, and fibroblasts, as well as the release of cytokines and growth factors, are commonly observed during wound-healing phasesnullnullnull 1, 2 null.</p><p>Cytokines such asinterleukin-1alpha  IL-1α , IL-1β, andtumornecrosisfactor-alpha  TNF-α  have a key role in the wound healing process  nullnullnull 1, 2 null. These proteins trigger or enhance inflammation nullnullnull (<xref ref-type="bibr" rid="B02">2</xref>) null. IL-1β and TNF-α, for instance, are produced by macrophages, keratinocytes, vascular endothelial cells, fibroblasts, monocytes, and T lymphocytes in wounds nullnullnull (<xref ref-type="bibr" rid="B03">3</xref>) null. Another factor present in the inflammatory phase of skin lesions is thegranulocytecolonystimulatingfactor  G-CSF , whichhas the ability toaccelerate hematopoiesis in the bone marrow andmakethese cells availableinthe bloodstream. Consequently, myeloid cells such as mature neutrophils are released into the peripheral circulation. Treatment for 4 to 5 days of G-CSF mice results in an increase in the number of circulating neutrophils, probably due to increased granulopoiesis and to an indirect effect of G-CSF on neutrophil mobilizationnullnullnull 4, 5 null. Consequently, more mature neutrophils are developed and released into peripheral circulation. Chemoattractant substances establish gradients that guide neutrophils and other types of leukocytes into the wound sitesnullnullnull (<xref ref-type="bibr" rid="B06">6</xref>) null.</p><p>In addition, inflammatory and anti-inflammatory cytokines are essential regulators of wound repair and their balance is fundamental for optimum woundclosure. The role ofIL-10 is to limit and terminate inflammatory responses. Moreover, it regulates growth and/or differentiation of various immune cells, keratinocytes, and endothelial cells.</p><p>Several factors can interfere in one or more phasesofthis process and affect wound healing. When associatedwithdiabetes types 1 and 2 for long periods, hyperglycemia affects the wound healing process through one or more biological mechanisms, by giving rise to exacerbated and prolonged cutaneous inflammation, micro- and macro-circulatory dysfunction nullnullnull 7, 8 null, and impaired neuropeptide signalingnullnullnull (<xref ref-type="bibr" rid="B09">9</xref>) null. These effects result in decreased release of cytokinesandgrowth factors and poor oxygen supply to the woundnullnullnull 10, 11 null, and these factors also contribute to slow wound repairnullnullnull (<xref ref-type="bibr" rid="B10">10</xref>) null.</p><p>The search for wound dressings capable of simultaneously protecting the wound and contributing to healing modulation is, therefore, highly relevant for patients with diabetes, which sometimes developahyperglycemic state. The use of natural polymers in dressingmaterialsintroduces important advantages, such as improved biocompatibility and biodegradability, non-toxicity, safety, similarity to the extracellular matrix, as well as the ability to induce and stimulate wound healingnullnullnull (<xref ref-type="bibr" rid="B12">12</xref>) null. Chitosan and alginate are biopolymers widely used in the production of wound dressings.</p><p>A clinical studythatcompared the use of chitosan wound dressing to a traditionalVaseline gauze  control  in patients with unhealed chronic wounds, including diabetic foot ulcers, showed promising resultsnullnullnull (<xref ref-type="bibr" rid="B13">13</xref>) null. The authors noticed woundreepithelializationafter 4 weeks of treatment and patients reported lower pain levels when chitosan was used. Chitosan consists of N-acetylglucosamine and N-glucosamine units and, according to Karri et al.nullnullnull (<xref ref-type="bibr" rid="B14">14</xref>) null, chitosan can depolymerize and release N-acetylglucosamine, which initiates fibroblast proliferation and helps in ordered collagen deposition.</p><p>Alginate also showsapositive influence in diabetic wound healing. Its injection in mice lesions is capableofreducingthe wound sizeby about 50% tendays after the first applicationnullnullnull (<xref ref-type="bibr" rid="B15">15</xref>) null. When calcium alginate dressings contact exudative lesions, the calcium ions are exchanged with sodium ions present in the exudate, resulting in the formation of a sodium-alginate gel. This gel keeps the lesion moist, promotes tissue granulation, and accelerates epithelization, consequently improving the healing processnullnullnull (<xref ref-type="bibr" rid="B16">16</xref>) null.</p><p>When combined, chitosan and alginate may form a stable polyelectrolyte complex  PEC  that results inrelatively transparentfilm capable of swelling in the presence of body fluids, such as exudates, with appropriate mechanical propertiesnullnullnull 17, 18 null. Chitosan-alginate membranes are capable of modulating the inflammatory phase, stimulating the proliferation of fibroblasts and the production of collagen fibers, accelerating cutaneous wound healing in the earlier phases, and improving the quality of the scar tissuenullnullnull (<xref ref-type="bibr" rid="B17">17</xref>) null. These findings strongly support the hypothesis that chitosan-alginate membranes could exert beneficial effects on the healing process of wounds in patients with diabetes with lesions of both acute and chronic origins.</p><p>Since no reports have been foundwith adetailed analysis of the use of dense chitosan-alginate PEC films to treat skin lesions of hyperglycemic animals, the aim of this work was to evaluate the efficacy ofchitosan andalginatemembrane  CAM  dressings on skin wounds of diabetes animal models. The results showed that CAM modulated the cytokines IL-1α, IL-1β, TNF-α, G-CSF, and IL-10, resulting in better collagen III deposition in cutaneous lesions of mice.</p></sec-type><sec-type sec-type="materials|methods"><title>Material and Methods</title><sec><title>Animals</title><p>The animals  eight-week-old male C57BL/6J mice  were kept under specific pathogen-free conditions in individual cages maintained at 21 ° C, in light-controlled conditions  (<xref ref-type="bibr" rid="B12">12</xref>) (<xref ref-type="bibr" rid="B-12">-12</xref>) h light and dark cycles , and received a standard solid diet and water<italic>ad libitum</italic>.</p></sec><sec><title>Chitosan-alginate membranes</title><p>The membranes were prepared as reported by Pires and Moraes    (<xref ref-type="bibr" rid="B19">19</xref>) . Briefly, a chitosan  lot #109K0043V, 96% deacetylation degree , Sigma-Aldrich, Germany   solution at 1%  w/v   180 mL, in 2% v/v acetic acid  was mixed with 0.5% sodium alginate  medium viscosity from<italic>Macrocystis</italic><italic>pyrifera</italic>, Sigma-Aldrich, lot #058K0126 aqueous solution  360 mL  at 25 ° C under stirring first at 500 rpm . After being mix ed , the material was further homogenized at 1000 rpm for 1 0 min. Then, 26.0 mL of 2 mol /L NaOH aqueous solution and 7.2 mL of 2%  w/v  CaCl<sub>2</sub>aqueous solution were added to the suspension. After deaeration , the mixture was transferred to four polystyrene Petri dishes  (<xref ref-type="bibr" rid="B15">15</xref>) cm in diameter  and dried at 60 ° C for 6 h. Then, the membranes were immersed in 150 mL of 2%  w/v  CaCl<sub>2</sub>aqueous solution for 30 min and washed twice with 200 mL of deionized water. Next , the biomaterial was dried at room temperature for 24 h and sterilized by exposure to ethylene oxide at Acecil Central de Esterilização Comércio e Indústria  Brazil . The morphology of the membranes was evaluated by scanning electron microscopy  SEM , using a LEO 440 microscope LEO Electron Microscopy Ltd., UK operating at 10 kV and 50 pA . T he samples were first dried, attached to a suitable metallic support , and coated with a 92 Å - thick gold layer  mini Sputter coater, SC 7620 , VG Microtech , UK  . Samples fractured with liquid nitrogen before metallization were used to obtain cross - section images. The membrane properties are summarized in Table 1 and their typical aspect is illustrated in Figure 1.</p></sec><sec><title>Induction of diabetes mellitus</title><p>Diabetes mellitus was induced by streptozotocin  60 mg·kg<sup>–</sup><sup>1</sup>·d ays<sup>–</sup><sup>1</sup>for 5 days , intraperitoneal ly  Sigma<sup>®</sup>, USA   as reported previously by Yu et al.  (<xref ref-type="bibr" rid="B20">20</xref>) . Two weeks after induction, blood was drawn from the animal tail veins and glucose concentration was analyzed using an Accu-Chek Active glucometer  Roche, Switzerland . Animals with blood glucose concentrations above 250 mg/dL were considered diabetic and selected for the study.</p><p>The Ethics Committee of the University of Campinas approved all experiments  Protocol number : 3950-1/2015 . The cutaneous wound was performed on the same day of diabetes confirmation. For surgical intervention, the mice were anesthetized with intraperitoneal ketamine hydrochloride  180 mg/kg body weight  and xylazine hydrochloride  8 mg/kg body weight  (<xref ref-type="bibr" rid="B21">21</xref>) . The animals were positioned in dorsal decubitus, the dorsal area was shaved and rinsed with alcohol 70% , and two circular wounds were produced by full epidermis removal using a 6.0 mm punch  Mil tex<sup>®</sup>Inc. , USA  . Previously hydrated chitosan-alginate membranes and 0.9%  w/v  NaCl aqueous solution were placed on each dorsal excision site. After the wound procedure, the animals received 20 mg/kg of intraperitoneal tramadol chlorhydrate  Medley Pharmaceutical Industry , Brazil  , once a day for two days after wound induc tion  (<xref ref-type="bibr" rid="B22">22</xref>) .</p><p>The animals were divided into two groups and placed individually in numbered cages : the CAM group, which was treated with the chitosan-alginate membranes  circular shape, 6 mm in diameter  previously moistened with 0.9%  w/v  NaCl aqueous solution ; and the control group  CG , which was treated only with 0.9% saline  500 μL per lesion . The wounds of all animals were hydrated daily with 0.9% saline  500 μL  until the 10th day of follow-up. The chitosan-alginate membranes were not removed during the treatment.</p></sec><sec><title>Wound healing assessment</title><p>To evaluate wound closure, the lesions were photographed daily by the same examiner with a Canon<sup>®</sup>Power Shot digital camera  model SX400 IS , Japan  . A tripod was used to maintain the same camera-to-wound distance in all experiments. The wound area was measured using the ImageJ software  National Institutes of Health, USA  . Wound closure  Wc   was defined as the reduction of wound area and the results are reported as percentage of the original lesion area, as follows : Wc = d t / d<sub>0</sub>× 100, where d<sub>0</sub>refers to the total lesion area immediately after wounding and d t to the wound area still uncovered with epidermis at time t.</p><p>The total wound length was deﬁned as the distance between opposite wound edges. The wound edge was determined based on the typical features of normal skin and newly formed dermal tissue. Since the chitosan-alginate membrane is transparent, it was possible to monitor the wound aspect and size without removing it.</p></sec><sec><title>Tissue processing and staining</title><p>After anesthetizing the mice with intraperitoneal ketamine hydrochloride  180 mg/kg body weight  and xylazine hydrochloride  8 mg/kg body weight   (<xref ref-type="bibr" rid="B21">21</xref>) , the fragments of skin of all groups were collected at days 1, 2, 5, and 10 post-lesion. After the surgical procedure, all animals were euthanized with an overdose of anesthetic, in accordance with ethical standards. The dissected skin tissues were fixed by immersion in paraformaldehyde in distilled water  4% , dehydrated in increasing concentrations of ethanol, followed by immersion in xylol and embedded in paraffin. The blocks were sectioned at 5.0 µm and placed on microscope slides. The wound sections were stained with hematoxylin and eosin. Digital images were captured under an Olympus  Japan photomicroscope  model U-LH100HG , and representative images of the histological structures were recorded using a digital image capture and analysis system  Olympus camera, model U-TVO.63XC / T2 .</p><p>The histological sections were stained using the 1% Picrosirius technique  (<xref ref-type="bibr" rid="B23">23</xref>) and analyzed under polarized light to evaluate types I and III collagen fibers. Fibers were identified by their birefringence pattern  type I : red, orange, and yellow and type III : green . The density of types I and III collagen fibers  per square micrometer  was determined using the Image Pro Plus version 6.0  Media Cybernetics, LP, USA .</p></sec><sec><title>Morphometric analysis</title><p>The number of leukocytes, fibroblasts, and new vessels and capillaries was determined in the injured area 5 and 10 days after wounding at 100 × magnification. Fifteen areas of 100 μm were analyzed in each region. The areas analyzed were determined by following a straight line, always moving the field in a single direction, with spacing of 100 to 300 μm between two regions analyzed depending on the characteristic of the repair region, keeping five areas below the injured epidermis, five in a lower region , and five areas close to the flesh pa n niculus  (<xref ref-type="bibr" rid="B24">24</xref>) . This morphometric analysis was performed by blinded raters.</p></sec><sec><title>Cytokine contents in wound tissue</title><p>Wound lesion samples collected at 1, 2, 5, and 10 days after wounding were immediately packed in dry ice and kept frozen  – 80° C . The concentratio ns of IL-1α, IL-1β, G-CSF, TNF- α, and IL-10 cytokines were measured in scar tissue homogenates using Bio- plex kit according to the manufacturer ' s instructions  Bio- plex Pro Assays, Bio-Rad Laboratories, Life Science Group , USA   and normalized by protein concentration determined by the Bradford method  (<xref ref-type="bibr" rid="B25">25</xref>) .</p></sec><sec><title>Statistical analysis</title><p>The results are reported as mean s ±SE. Student ' s<italic>t</italic>-test for independent samples was used to compare the mean values of the cytokine contents in wound tissue and for the analysis of type I and III collagen fibers in both groups. Two-way a nalysis of variance  ANOVA  was used to compare the mean wound area values from days 0 to 10 after injury. In all cases, the level of significance considered enough to reject the null hypothesis was 5%  P&lt; 0.05 . Data were analyzed using the GraphPad Prism 7.</p></sec></sec-type><sec-type sec-type="results"><title>Results</title><sec><p>Data from macroscopic analysis of the wound area from 0 to 10 days after injury indicated that the CAM group showed a smaller wound area on the 6 th day  P &lt;0.05  compared t o the CG  Figure 2A and B . According to the microscopic qualitative analysis  histological sections stained with h ematoxylin and e osin , on day 10 after lesioning, the CAM group had lower inflammatory infiltrate  Figure 3C , as well as more organized dermis connective tissue  Figure (<xref ref-type="bibr" rid="B03">3</xref>) . In addition, all animals in the CAM group  n= (<xref ref-type="bibr" rid="B05">5</xref>)  had complete reepithelization.</p><p>M orphometric analys e s performed on the 5 th and 10th days after the lesion indicated lower numbers of leukocytes  Figure 3<xref ref-type="fig" rid="f03">Figure 3</xref>3 B and C , blood vessels  Figure 3D and E   P &lt;0.05 , and fibroblasts  Figure 3<xref ref-type="fig" rid="f03">Figure 3</xref>3 F and G  in the CAM group compared to the CG.</p><fig id="f03"><label>Figure 3.</label><caption><title><bold>Figure</bold><bold>3.</bold> <bold>A</bold>, Microscopic aspect of skin excisional wounds in the c ontrol (CG) and c hitosan and a lginate m embrane (CAM) groups, 0, 2, 4, 6 , and 10 days  post - wounding . Sections were stained with hematoxylin and eosin,  and the images were acquired under a final magnifica tion of 10 × (scale bar s: 100 µm). DE: dermis ; EP: epidermis ; SCAB: dry scab. Quantification of leucocytes (<bold>B</bold>and<bold>C</bold>), vessels (<bold>D</bold>and<bold>E</bold>), and fibroblasts (<bold>F</bold>and<bold>G)</bold> on days 5 and 10  post - wounding .  D ata are reported as means±SE of 5 animals per group. * P&lt; 0.05<italic>vs</italic>CG (Student's<italic>t</italic>-test) .</title></caption></fig><p>In the qualitative analysis performed on the 10 th day, the CAM group showed a more regular and uniform arrangement of type I and III collagen fibers compared to the CG  Figure 4A , but there was no statistical difference in the quantitative analysis  Figure 4B and<xref ref-type="fig" rid="f04">Figure 4B and</xref>d C .</p><fig id="f04"><label>Figure 4.</label><caption><title><bold>Figure</bold><bold>4.</bold> <bold>A</bold>, Picros irius red-stained sections of wounds under polarized light followed by sections without polarization of c ontrol (CG) and c hitosan and a lginate m embrane (CAM) groups, 5 and 10 days  post - wounding . <bold>B</bold>and<bold>C</bold>, Analysis of collagen fibers (red and yellow and green) area of CG and CAM groups on day s 5  and 10 post - wounding . The images were acquired under a final mag nification of 10 × (scale bars : 100 µ m).  The data are reported as means±SE of 5 animals per group (Student's<italic>t</italic>-test) .</title></caption></fig><p>The multiplex assays used to determine cytokine level s in the wound area showed that IL-1α  P= 0.036   Figure 5A  and IL-1β  P= 0.012   Figure 5B were higher in the CAM group compared to the CG on day 1. TNF-α  P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B44">044</xref>)  and IL-10  P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B28">028</xref>) were lower in the CAM group compared to the CG on day 1. On day 2 , the CAM group had higher concentration s of IL-1β  P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B13">013</xref>) , G-CSF  P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B02">0002</xref>) , and TNF-α P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B14">014</xref>) Figure 5B, C and D . On day 5 post-injury, G-CSF  P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B38">038</xref>)  and TNF-α  P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B03">0003</xref>)  concentrations were lower in the CAM group compared with the CG  Figure 5C and<xref ref-type="fig" rid="f05">Figure 5C and</xref>d D . A fter 10 days, TNF-α  P= (<xref ref-type="bibr" rid="B00">0</xref>) . (<xref ref-type="bibr" rid="B15">015</xref>)   Figure 5D  and IL-10  P= 0.027   Figure 5E  concentrations were lower in the CAM group compared with the CG.</p><fig id="f05"><label>Figure 5.</label><caption><title><bold>Figu</bold><bold>re 5.</bold>P r oduction of cytokines during wound healing. Concentrations of<bold>A</bold>) i nterleukin-1 a lpha ( I L-1α) ,<bold>B</bold>) IL-1β ,<bold>C</bold>) g ranulocyte c olony s timulating f actor (G-CSF),<bold>D</bold>) t umor n ecrosis f actor- a lpha (TNF-α) , and<bold>E</bold>) IL-10 in wound tissue of c ontrol (CG) and c hitosan and a lginate m embrane (CAM) groups on days 1, 2, 5 , and 10 post - wounding. D ata are reported as mean s ±SE of 5 animals per group. * P&lt; 0.05 ,  *** P&lt; 0.001 <italic>vs</italic>CG (Student's<italic>t</italic>-test) . </title></caption></fig></sec></sec-type><sec-type sec-type="discussion"><title>Discussion</title><p>Polysaccharide materials have been used in wound healing over many yearsnullnullnull 12, 17, 18, 26, 27 null. Even though the wound healing process mediated by the use of these biomaterials is not yet fully understood, it is well-known that an ideal wound dressing should provide a moist environment, protect the wound from extraneous agents, absorb excess exudates, allow gas exchange, be comfortable, biocompatible, and aid in tissue regenerationnullnullnull (<xref ref-type="bibr" rid="B28">28</xref>) null.</p><p>Recently, it has been reported thatCAMsmodulate the inflammatory phase and stimulate fibroplasia and collagen fibers, accelerating the wound healing process in healthy ratsnullnullnull (<xref ref-type="bibr" rid="B17">17</xref>) null. Positive results for wound healing in a juvenile dermatomyositis patient was also reported with the use ofCAMsassociated with fibrin glue and autologous fibroblasts and keratinocytesnullnullnull (<xref ref-type="bibr" rid="B29">29</xref>) null. According to the SEM analysis, the membrane shows a lamellar and homogeneous structure, as also reported byZorzi Bueno andMoraes nullnullnull (<xref ref-type="bibr" rid="B30">30</xref>) nullandPiresandMoraes (<xref ref-type="bibr" rid="B19">19</xref>) . The SEM analysis also showed that no pores are found on the membrane surface at the microscopic scale, indicating that it could provide appropriate protection to the wound against the permeation of contaminants from the environment, a property further reinforced by its fibrous structure nullnullnull 12, 17, 19 null.</p><p>In addition, the membrane is transparent  Figure1 and 2A , especiallywhen wet, allowing lesion inspection during treatment without the need to remove it.The membrane isalsovery thin, even after swelling due to the absorption of fluids  Table 1 , being potentially comfortable to the patient. According to Ma et al.nullnullnull (<xref ref-type="bibr" rid="B31">31</xref>) null, artificial skin substitutes should be thinner than the human dermis  0.5 to 2 mm . Furthermore, the membrane formulation used is resistant enough to behandledat the patient's bedside, and despitebeing capable of absorbingup to 14 g/g of saline solution, its structure is sufficiently stable in this solution for at least a week, with a mass loss of only 12%. This resultwascorroborated<italic>in vivo</italic>, since the membrane remainedintactalong the study, while allowing the removal ofexcesswound exudate. The mechanical propertiesof the membranewereconsidered to beadequate regarding tensile strength; however, the biomaterial used shows lowelongation at break  3%  when dry, which limits its use to non-articulated body regions. Moist membranes, on the other hand, have significantly improved elongationnullnullnull (<xref ref-type="bibr" rid="B18">18</xref>) null. The membrane used in this work fulfills, then, many requirements of an ideal skin wound dressing, being also easily maintainedonthe lesion site afterbeingplaced over the lesions.</p><p>Deficient wound healing is observed in patients with diabetes mellitus with excessive or uncontrolled inflammation nullnullnull (<xref ref-type="bibr" rid="B32">32</xref>) null. Several reasons can be attributed to the delay in re-epithelialization in diabetes mellitus including various types of cells and molecular effectors, which become destructive and promote apoptosis inthediabetic wound bednullnullnull (<xref ref-type="bibr" rid="B33">33</xref>) null.</p><p>To evaluate the effect of CAM-mediated therapy on the wound healing process, we first observed the rate of wound closure and compared it with the results for CG at different time points throughout the 10-day treatment period. The tissue repair of the injured area of the hyperglycemic animals evolved verysimilarlyto theCAM group, with completereepithelialization10 days after injury. On the other hand, there was a decrease in inflammatory infiltrate cellsinthe CAM groupcomparedwiththeCG, whichmay have contributed to the difference in wound contraction 6 days after injury.</p><p>In the qualitative analysis of collagen staining byPicrosirius, an increase of well-organized collagen fibers was observed in the CAM group. Typically, in a normal process of skin repair, type III collagen deposition is observed soon after injury, which is replaced by type I collagen in the final phase of repair nullnullnull (<xref ref-type="bibr" rid="B34">34</xref>) null.</p><p>The healing process is regulated by a complex signaling network involving various chemokines, cytokines, and growth factors. In this study, theCAMsmodulated the increase in the expression of the inflammatory cytokines, such as IL-1β and IL-1α. These cytokines modulate the activity of various types of cells implicated in tissue repair. In diabeticswith wounds, granulation tissue formation is seriously impaired because of the reduced proliferation of fibroblasts, lower levels of collagen deposition, and wound contraction nullnullnull 35, 36 null. However, the literature shows that the healing process is characterized by a low-grade inflammatory state in the case of hyperglycemia associated to formation of advanced glycation products  AGEs nullnullnull (<xref ref-type="bibr" rid="B11">11</xref>) null.Occurrence of hyperglycemia in the animals in this study may have contributed to a lower expression of the proinflammatory cytokine TNF-α at day 1 after wounding.</p><p>In spite ofthis, forty-eight hours after membrane application, an increase of TNF-α and G-CSF concentrations was observed. TNF-α is a pleiotropic cytokine, with the ability to affect almost every tissue and organ.Also, this cytokine is chemotactic for macrophages and participates inmacrophage activation and angiogenesis stimulationnullnullnull (<xref ref-type="bibr" rid="B36">36</xref>) null. In addition, TNF-α promoteschoroidal neovascularization by upregulating the vascular endothelial growth factor expression in retinal pigment epithelial cells through reactive oxygen species-dependent β-catenin activation and fibroblast proliferationnullnullnull (<xref ref-type="bibr" rid="B37">37</xref>) null.</p><p>G-CSF is a hematopoietic cytokine produced by monocytes, fibroblasts, and endothelial cells.Furthermore, bone marrow-derived stem/progenitor cells could be strongly mobilized into circulation by G-CSFnullnullnull (<xref ref-type="bibr" rid="B38">38</xref>) null. Five days after wounding, there was a decrease in the level of G-CSF and TNF-α. These results seem toindicatea contributiontomaintaininginflammation in a well-controlled state, indicating that CAM may be a promising therapy for wounds occurring in patients with diabetes.</p><p>IL-10 is an anti-inflammatory cytokine withasignificant impact on healing and epithelialization. Its overexpression decreases inflammatory mediators and promotes regenerative healing inanadult model of scar formationnullnullnull (<xref ref-type="bibr" rid="B39">39</xref>) null. We detected that this cytokine level was decreased in the CAM group 10 days after wounding. Interestingly, TNF-α was not detected in the animals treated with CAM in the same period, but it was observed in the CG, indicating that there is a synergistic relationship between these two cytokines. These results suggestedthat treatment with CAM initially upregulatedthe expression of pro-inflammatory IL-1β, IL1α, andTNF-αcytokines, and that the anti-inflammatory IL-10 cytokines contributed to mediate the transition between phases of wound healing.</p><p>Thus, lesion healing ofdiabeticsis a complex process and the interaction between chemokines, cytokines, and growth factors will determine the process evolution. In this study, the inflammatory phase of cutaneous lesions of hyperglycemic mice was modulatedby the use ofCAM, mostly regarding the cytokines IL-1α, IL-1β, TNF-α, G-CSF, and IL-10, resulting in better collagen III deposition. However, further studies are needed to better understand the healing stages associated with CAM use.</p></sec-type><sec-type sec-type="ack"><title>Acknowledgments</title><p>The authors would like to thank the Coordination for the Improvement of Higher Education Personnel  CAPES  and the National Council for Scientific and Technological Development  CNPq  forthe supportofthis study.</p></sec-type></body><back><ref-list><title>References</title><ref id="B01"><label>1</label><mixed-citation>1. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med 2014; 6: 265sr6, doi: 10.1126/scitranslmed.3009337.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eming</surname><given-names>SA</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><name><surname>Tomic-Canic</surname><given-names>M</given-names></name></person-group><article-title>Wound repair and regeneration: mechanisms, signaling, and translation</article-title><source xml:lang="en">Sci Transl Med</source><year>2014</year><volume>6</volume><fpage>265sr6,</fpage></element-citation></ref><ref id="B02"><label>2</label><mixed-citation>2. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007; 127: 514–525.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eming</surname><given-names>SA</given-names></name><name><surname>Krieg</surname><given-names>T</given-names></name><name><surname>Davidson</surname><given-names>JM</given-names></name></person-group><article-title>Inflammation in wound repair: molecular and cellular mechanisms</article-title><source xml:lang="en">J Invest Dermatol</source><year>2007</year><volume>127</volume><fpage>514</fpage><lpage>525</lpage></element-citation></ref><ref id="B03"><label>3</label><mixed-citation>3. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17: 1–14.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group><article-title>Toll-like receptors in innate immunity</article-title><source xml:lang="en">Int Immunol</source><year>2005</year><volume>17</volume><fpage>1</fpage><lpage>14</lpage></element-citation></ref><ref id="B04"><label>4</label><mixed-citation>4. Gardner JC, Noel JG, Nikolaidis NM, Karns R, Aronow BJ, Ogle CK, et al. G-CSF drives a posttraumatic immune program that protects the host from infection. J Immunol 2014; 192: 2405–2417, doi: 10.4049/jimmunol.1302752.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>JC</given-names></name><name><surname>Noel</surname><given-names>JG</given-names></name><name><surname>Nikolaidis</surname><given-names>NM</given-names></name><name><surname>Karns</surname><given-names>R</given-names></name><name><surname>Aronow</surname><given-names>BJ</given-names></name><name><surname>Ogle</surname><given-names>CK</given-names></name></person-group><article-title>G-CSF drives a posttraumatic immune program that protects the host from infection</article-title><source xml:lang="en">J Immunol</source><year>2014</year><volume>192</volume><fpage>2405</fpage><lpage>2417,</lpage></element-citation></ref><ref id="B05"><label>5</label><mixed-citation>5. Wengner AM, Pitchford SC, Furze RC, Rankin SM. The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood 2008; 111: 42–49, doi: 10.1182/blood-2007-07-099648.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wengner</surname><given-names>AM</given-names></name><name><surname>Pitchford</surname><given-names>SC</given-names></name><name><surname>Furze</surname><given-names>RC</given-names></name><name><surname>Rankin</surname><given-names>SM</given-names></name></person-group><article-title>The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation</article-title><source xml:lang="en">Blood</source><year>2008</year><volume>111</volume><fpage>42</fpage><lpage>49,</lpage></element-citation></ref><ref id="B06"><label>6</label><mixed-citation>6. Su Y, Richmond A. Chemokine regulation of neutrophil infiltration of skin wounds. Adv Wound Care (New Rochelle) 2015; 4: 631–640, doi: 10.1089/wound.2014.0559.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Richmond</surname><given-names>A</given-names></name></person-group><article-title>Chemokine regulation of neutrophil infiltration of skin wounds</article-title><source xml:lang="en">Adv Wound Care (New Rochelle)</source><year>2015</year><volume>4</volume><fpage>631</fpage><lpage>640,</lpage></element-citation></ref><ref id="B07"><label>7</label><mixed-citation>7. Wetzler C, Ka H, Stallmeyer B, Pfeilschifter J, Frank S, Pharmakologie Z Der, et al. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 8: 245–253, doi: 10.1046/j.1523-1747.2000.00029.x.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wetzler</surname><given-names>C</given-names></name><name><surname>Ka</surname><given-names>H</given-names></name><name><surname>Stallmeyer</surname><given-names>B</given-names></name><name><surname>Pfeilschifter</surname><given-names>J</given-names></name><name><surname>Frank</surname><given-names>S</given-names></name><name><surname>PharmakologieZ</surname><given-names>Der</given-names></name></person-group><article-title>Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair</article-title><source xml:lang="en">J Invest Dermatol</source><year>2000</year><volume>8</volume><fpage>245</fpage><lpage>253,</lpage></element-citation></ref><ref id="B08"><label>8</label><mixed-citation>8. Andrade TAM, Masson-Meyers DS, Caetano GF, Terra VA, Ovidio PP, Jordão-Júnior AA, et al. Skin changes in streptozotocin-induced diabetic rats. Biochem Biophys Commun 2017; 490: 1154–61, doi: 10.1016/j.bbrc.2017.06.166.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>TAM</given-names></name><name><surname>Masson-Meyers</surname><given-names>DS</given-names></name><name><surname>Caetano</surname><given-names>GF</given-names></name><name><surname>Terra</surname><given-names>VA</given-names></name><name><surname>Ovidio</surname><given-names>PP</given-names></name><name><surname>Jordão-Júnior</surname><given-names>AA</given-names></name></person-group><article-title>Skin changes in streptozotocin-induced diabetic rats</article-title><source xml:lang="en">Biochem Biophys Commun</source><year>2017</year><volume>490</volume><fpage>1154</fpage><lpage>61,</lpage></element-citation></ref><ref id="B09"><label>9</label><mixed-citation>9. Komesu MC, Tanga MB, Buttros KR, Nakao C. Effects of acute diabetes on rat cutaneous wound healing. Pathophysiology 2004; 11: 63–67, doi: 10.1016/j.pathophys.2004.02.002.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komesu</surname><given-names>MC</given-names></name><name><surname>Tanga</surname><given-names>MB</given-names></name><name><surname>Buttros</surname><given-names>KR</given-names></name><name><surname>Nakao</surname><given-names>C</given-names></name></person-group><article-title>Effects of acute diabetes on rat cutaneous wound healing</article-title><source xml:lang="en">Pathophysiology</source><year>2004</year><volume>11</volume><fpage>63</fpage><lpage>67,</lpage></element-citation></ref><ref id="B10"><label>10</label><mixed-citation>10. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219–1222, doi: 10.1172/JCI32169.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brem</surname><given-names>H</given-names></name><name><surname>Tomic-Canic</surname><given-names>M</given-names></name></person-group><article-title>Cellular and molecular basis of wound healing in diabetes</article-title><source xml:lang="en">J Clin Invest</source><year>2007</year><volume>117</volume><fpage>1219</fpage><lpage>1222,</lpage></element-citation></ref><ref id="B11"><label>11</label><mixed-citation>11. Baltzis D, Eleftheriadou I, Veves A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Adv Ther 2014; 817–836, doi: 10.1007/s12325-014-0140-x.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltzis</surname><given-names>D</given-names></name><name><surname>Eleftheriadou</surname><given-names>I</given-names></name><name><surname>Veves</surname><given-names>A</given-names></name></person-group><article-title>Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights</article-title><source xml:lang="en">Adv Ther</source><year>2014</year><volume>817–836,</volume></element-citation></ref><ref id="B12"><label>12</label><mixed-citation>12. Straccia MC, d'Ayala GG, Romano I, Oliva A, Laurienzo P. Alginate hydrogels coated with chitosan for wound dressing. Mar Drugs 2015; 13: 2890–2908, doi: 10.3390/md13052890.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straccia</surname><given-names>MC</given-names></name><name><surname>d'Ayala</surname><given-names>GG</given-names></name><name><surname>Romano</surname><given-names>I</given-names></name><name><surname>Oliva</surname><given-names>A</given-names></name><name><surname>Laurienzo</surname><given-names>P</given-names></name></person-group><article-title>Alginate hydrogels coated with chitosan for wound dressing</article-title><source xml:lang="en">Mar Drugs</source><year>2015</year><volume>13</volume><fpage>2890</fpage><lpage>2908,</lpage></element-citation></ref><ref id="B13"><label>13</label><mixed-citation>13. Mo X, Cen J, Gibson E, Wang R, Percival SL. An open multicenter comparative randomized clinical study on chitosan. Wound Repair Regen 2015; 23, doi: 10.1111/wrr.12298.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>X</given-names></name><name><surname>Cen</surname><given-names>J</given-names></name><name><surname>Gibson</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Percival</surname><given-names>SL</given-names></name></person-group><article-title>An open multicenter comparative randomized clinical study on chitosan</article-title><source xml:lang="en">Wound Repair Regen</source><year>2015</year><volume>23,</volume></element-citation></ref><ref id="B14"><label>14</label><mixed-citation>14. Karri VV, Kuppusamy G, Talluri SV, Mannemala SS, Kollipara R, Wadhwani AD, et al. Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing. Int J Biol Macromol 2016; 93: 1519–1529, doi: 10.1016/j.ijbiomac.2016.05.038.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karri</surname><given-names>VV</given-names></name><name><surname>Kuppusamy</surname><given-names>G</given-names></name><name><surname>Talluri</surname><given-names>SV</given-names></name><name><surname>Mannemala</surname><given-names>SS</given-names></name><name><surname>Kollipara</surname><given-names>R</given-names></name><name><surname>Wadhwani</surname><given-names>AD</given-names></name></person-group><article-title>Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing</article-title><source xml:lang="en">Int J Biol Macromol</source><year>2016</year><volume>93</volume><fpage>1519</fpage><lpage>1529,</lpage></element-citation></ref><ref id="B15"><label>15</label><mixed-citation>15. Tellechea A, Silva EA, Min J, Leal EC, Auster ME, Pradhan-Nabzdyk L, et al. Alginate and DNA gels are suitable delivery systems for diabetic wound healing. Int J Low Extrem Wounds 2015; 14: 146–153, doi: 10.1177/1534734615580018.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tellechea</surname><given-names>A</given-names></name><name><surname>Silva</surname><given-names>EA</given-names></name><name><surname>Min</surname><given-names>J</given-names></name><name><surname>Leal</surname><given-names>EC</given-names></name><name><surname>Auster</surname><given-names>ME</given-names></name><name><surname>Pradhan-Nabzdyk</surname><given-names>L</given-names></name></person-group><article-title>Alginate and DNA gels are suitable delivery systems for diabetic wound healing</article-title><source xml:lang="en">Int J Low Extrem Wounds</source><year>2015</year><volume>14</volume><fpage>146</fpage><lpage>153,</lpage></element-citation></ref><ref id="B16"><label>16</label><mixed-citation>16. Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci 2012; 37: 106–126, doi: 10.1016/j.progpolymsci.2011.06.003.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Mooney</surname><given-names>DJ</given-names></name></person-group><article-title>Alginate: properties and biomedical applications</article-title><source xml:lang="en">Prog Polym Sci</source><year>2012</year><volume>37</volume><fpage>106</fpage><lpage>126,</lpage></element-citation></ref><ref id="B17"><label>17</label><mixed-citation>17. Caetano GF, Frade MA, Andrade TA, Leite MN, Bueno CZ, Moraes ÂM, et al. Chitosan-alginate membranes accelerate wound healing. J Biomed Mater Res B Appl Biomater 2015; 103: 1013–1022, doi: 10.1002/jbm.b.33277.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caetano</surname><given-names>GF</given-names></name><name><surname>Frade</surname><given-names>MA</given-names></name><name><surname>Andrade</surname><given-names>TA</given-names></name><name><surname>Leite</surname><given-names>MN</given-names></name><name><surname>Bueno</surname><given-names>CZ</given-names></name><name><surname>Moraes</surname><given-names>ÂM</given-names></name></person-group><article-title>Chitosan-alginate membranes accelerate wound healing</article-title><source xml:lang="en">J Biomed Mater Res B Appl Biomater</source><year>2015</year><volume>103</volume><fpage>1013</fpage><lpage>1022,</lpage></element-citation></ref><ref id="B18"><label>18</label><mixed-citation>18. Bombaldi de Souza RF, Bombaldi de Souza FC, Moraes A. Analysis of the performance of polysaccharide membranes in aqueous media as a tool to assist wound-dressing selection. ‎J Appl Polym Sci 2017; 134: 45386, doi: 10.1002/app.45386.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BombaldideSouza</surname><given-names>RF</given-names></name><name><surname>BombaldideSouza</surname><given-names>FC</given-names></name><name><surname>Moraes</surname><given-names>A</given-names></name></person-group><article-title>Bombaldi de Souza RF, Bombaldi de Souza FC, Moraes A Analysis of the performance of polysaccharide membranes in aqueous media as a tool to assist wound-dressing selection</article-title><source xml:lang="en">‎J Appl Polym Sci</source><year>2017</year><volume>134</volume><fpage>45386,</fpage></element-citation></ref><ref id="B19"><label>19</label><mixed-citation>19. Pires ALR, Moraes AM. Improvement of the mechanical properties of chitosan-alginate wound dressings containing silver through the addition of a biocompatible silicone rubber. J Appl Polym Sci 2015; 132, doi: 10.1002/app.41686.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>ALR</given-names></name><name><surname>Moraes</surname><given-names>AM</given-names></name></person-group><article-title>Improvement of the mechanical properties of chitosan-alginate wound dressings containing silver through the addition of a biocompatible silicone rubber</article-title><source xml:lang="en">J Appl Polym Sci</source><year>2015</year><volume>132,</volume></element-citation></ref><ref id="B20"><label>20</label><mixed-citation>20. Yu JW, Deng YP, Han X, Ren GF, Cai J, Jiang GJ. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice. Cardiovasc Diabetol 2016; 15: 88, doi: 10.1186/s12933-016-0408-3.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>JW</given-names></name><name><surname>Deng</surname><given-names>YP</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Ren</surname><given-names>GF</given-names></name><name><surname>Cai</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>GJ</given-names></name></person-group><article-title>Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice</article-title><source xml:lang="en">Cardiovasc Diabetol</source><year>2016</year><volume>15</volume><fpage>88,</fpage></element-citation></ref><ref id="B21"><label>21</label><mixed-citation>21. Jaber SM, Hankenson FC, Heng K, McKinstry-Wu A, Kelz MB, Marx JO. Dose regimens, variability, and complications associated with using repeat-bolus dosing to extend a surgical plane of anesthesia in laboratory mice. J Am Assoc Lab Anim Sci 2014; 53: 684–691.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaber</surname><given-names>SM</given-names></name><name><surname>Hankenson</surname><given-names>FC</given-names></name><name><surname>Heng</surname><given-names>K</given-names></name><name><surname>McKinstry-Wu</surname><given-names>A</given-names></name><name><surname>Kelz</surname><given-names>MB</given-names></name><name><surname>Marx</surname><given-names>JO</given-names></name></person-group><article-title>Dose regimens, variability, and complications associated with using repeat-bolus dosing to extend a surgical plane of anesthesia in laboratory mice</article-title><source xml:lang="en">J Am Assoc Lab Anim Sci</source><year>2014</year><volume>53</volume><fpage>684</fpage><lpage>691</lpage></element-citation></ref><ref id="B22"><label>22</label><mixed-citation>22. Hish GA Jr, Diaz JA, Hawley AE, Myers DD Jr, Lester PA. Effects of analgesic use on inflammation and hematology in a murine model of venous thrombosis. J Am Assoc Lab Anim Sci 2014; 53: 485–493.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HishGA</surname><given-names>Jr</given-names></name><name><surname>Diaz</surname><given-names>JA</given-names></name><name><surname>Hawley</surname><given-names>AE</given-names></name><name><surname>MyersDD</surname><given-names>Jr</given-names></name><name><surname>Lester</surname><given-names>PA</given-names></name></person-group><article-title>Hish GA Jr, Diaz JA, Hawley AE, Myers DD Jr, Lester PA Effects of analgesic use on inflammation and hematology in a murine model of venous thrombosis</article-title><source xml:lang="en">J Am Assoc Lab Anim Sci</source><year>2014</year><volume>53</volume><fpage>485</fpage><lpage>493</lpage></element-citation></ref><ref id="B23"><label>23</label><mixed-citation>23. Junqueira L, Carneiro J. Histologia Básica. 12a. Rio de Janeiro: Guanabara Koogan; 2013. p 527.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junqueira</surname><given-names>L</given-names></name><name><surname>Carneiro</surname><given-names>J</given-names></name></person-group><article-title>Histologia Básica 12a Rio de Janeiro: Guanabara Koogan; 2013</article-title><source xml:lang="en">p</source><year>527</year></element-citation></ref><ref id="B24"><label>24</label><mixed-citation>24. Cantaruti TA, Costa RA, de Souza KS, Vaz NM, Carvalho CR. Indirect effects of immunological tolerance to a regular dietary protein reduce cutaneous scar formation. Immunology 2017; 151: 314–323, doi: 10.1111/imm.12732.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantaruti</surname><given-names>TA</given-names></name><name><surname>Costa</surname><given-names>RA</given-names></name><name><surname>deSouza</surname><given-names>KS</given-names></name><name><surname>Vaz</surname><given-names>NM</given-names></name><name><surname>Carvalho</surname><given-names>CR</given-names></name></person-group><article-title>Indirect effects of immunological tolerance to a regular dietary protein reduce cutaneous scar formation</article-title><source xml:lang="en">Immunology</source><year>2017</year><volume>151</volume><fpage>314</fpage><lpage>323,</lpage></element-citation></ref><ref id="B25"><label>25</label><mixed-citation>25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254, doi: 10.1016/0003-2697(76)90527-3.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group><article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title><source xml:lang="en">Anal Biochem</source><year>1976</year><volume>72</volume><fpage>248</fpage><lpage>254,</lpage></element-citation></ref><ref id="B26"><label>26</label><mixed-citation>26. W P. Chitosan and alginate wound dressings: a short review. P SC, editor. Vol. 18. Trends in Biomaterials &amp; Artifical Organs; 2004. p 18–23.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W</surname><given-names>P</given-names></name></person-group><article-title>Chitosan and alginate wound dressings: a short review P SC, editor Vol 18 Trends in Biomaterials &amp; Artifical Organs; 2004</article-title><source xml:lang="en">p</source><year>0</year></element-citation></ref><ref id="B27"><label>27</label><mixed-citation>27. Bellini MZ, Caliari-Oliveira C, Mizukami A, Swiech K, Covas DT, Donadi EA, et al. Combining xanthan and chitosan membranes to multipotent mesenchymal stromal cells as bioactive dressings for dermo-epidermal wounds. J Biomater Appl 2015; 29: 1155–1166, doi: 10.1177/0885328214553959.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellini</surname><given-names>MZ</given-names></name><name><surname>Caliari-Oliveira</surname><given-names>C</given-names></name><name><surname>Mizukami</surname><given-names>A</given-names></name><name><surname>Swiech</surname><given-names>K</given-names></name><name><surname>Covas</surname><given-names>DT</given-names></name><name><surname>Donadi</surname><given-names>EA</given-names></name></person-group><article-title>Combining xanthan and chitosan membranes to multipotent mesenchymal stromal cells as bioactive dressings for dermo-epidermal wounds</article-title><source xml:lang="en">J Biomater Appl</source><year>2015</year><volume>29</volume><fpage>1155</fpage><lpage>1166,</lpage></element-citation></ref><ref id="B28"><label>28</label><mixed-citation>28. Wittaya-Areekul S, Prahsarn C, Sungthongjeen S. Development and in vitro evaluation of Chitosan-Eudragit RS 30D composite wound dressings. AAPS PharmSciTech 2006; 7: E30, doi: 10.1208/pt070130.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittaya-Areekul</surname><given-names>S</given-names></name><name><surname>Prahsarn</surname><given-names>C</given-names></name><name><surname>Sungthongjeen</surname><given-names>S</given-names></name></person-group><article-title>Development and in vitro evaluation of Chitosan-Eudragit RS 30D composite wound dressings</article-title><source xml:lang="en">AAPS PharmSciTech</source><year>2006</year><volume>7</volume><fpage>E30,</fpage></element-citation></ref><ref id="B29"><label>29</label><mixed-citation>29. Colpas PT, Alves PCM, Oliveira CC, Pires ALR, Moraes AM, Puzzi MB. Combining cell therapy with biopolymer films improves wound healing in a juvenile dermatomyositis patient. Surg Cosmet Dermatol 2018; 10: 28–35, doi: 10.5935/scd1984-8773.20181011129.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colpas</surname><given-names>PT</given-names></name><name><surname>Alves</surname><given-names>PCM</given-names></name><name><surname>Oliveira</surname><given-names>CC</given-names></name><name><surname>Pires</surname><given-names>ALR</given-names></name><name><surname>Moraes</surname><given-names>AM</given-names></name><name><surname>Puzzi</surname><given-names>MB</given-names></name></person-group><article-title>Combining cell therapy with biopolymer films improves wound healing in a juvenile dermatomyositis patient</article-title><source xml:lang="en">Surg Cosmet Dermatol</source><year>2018</year><volume>10</volume><fpage>28</fpage><lpage>35,</lpage></element-citation></ref><ref id="B30"><label>30</label><mixed-citation>30. Zorzi Bueno C, Moraes AM. Development of porous lamellar chitosan-alginate membranes: effect of different surfactants on biomaterial properties. J Appl Polym Sci 2011; 122: 624–631, doi: 10.1002/app.34192.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>ZorziBueno</surname><given-names>C</given-names></name><name><surname>Moraes</surname><given-names>AM</given-names></name></person-group><article-title>Zorzi Bueno C, Moraes AM Development of porous lamellar chitosan-alginate membranes: effect of different surfactants on biomaterial properties</article-title><source xml:lang="en">J Appl Polym Sci</source><year>2011</year><volume>122</volume><fpage>624</fpage><lpage>631,</lpage></element-citation></ref><ref id="B31"><label>31</label><mixed-citation>31. Ma J, Wang H, He B, Chen J. A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts. Biomaterials 2001; 22: 331–336, doi: 10.1016/S0142-9612(00)00188-5.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts</article-title><source xml:lang="en">Biomaterials</source><year>2001</year><volume>22</volume><fpage>331</fpage><lpage>336,</lpage></element-citation></ref><ref id="B32"><label>32</label><mixed-citation>32. Tellechea A, Kafanas A, Leal EC, Tecilazich F, Kuchibhotla S, Auster ME, et al. Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds 2013; 12: 4–11, doi: 10.1177/1534734612474303.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tellechea</surname><given-names>A</given-names></name><name><surname>Kafanas</surname><given-names>A</given-names></name><name><surname>Leal</surname><given-names>EC</given-names></name><name><surname>Tecilazich</surname><given-names>F</given-names></name><name><surname>Kuchibhotla</surname><given-names>S</given-names></name><name><surname>Auster</surname><given-names>ME</given-names></name></person-group><article-title>Increased skin inflammation and blood vessel density in human and experimental diabetes</article-title><source xml:lang="en">Int J Low Extrem Wounds</source><year>2013</year><volume>12</volume><fpage>4</fpage><lpage>11,</lpage></element-citation></ref><ref id="B33"><label>33</label><mixed-citation>33. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219–1222</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brem</surname><given-names>H</given-names></name><name><surname>Tomic-Canic</surname><given-names>M</given-names></name></person-group><article-title>Cellular and molecular basis of wound healing in diabetes</article-title><source xml:lang="en">J Clin Invest</source><year>2007</year><volume>117</volume><fpage>1219</fpage><lpage>1222</lpage></element-citation></ref><ref id="B34"><label>34</label><mixed-citation>34. Haukipuro K. Synthesis of collagen types I and III in reincised wounds in humans. Br J Surg 1991; 78: 708–712, doi: 10.1002/bjs.1800780624.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haukipuro</surname><given-names>K</given-names></name></person-group><article-title>Synthesis of collagen types I and III in reincised wounds in humans</article-title><source xml:lang="en">Br J Surg</source><year>1991</year><volume>78</volume><fpage>708</fpage><lpage>712,</lpage></element-citation></ref><ref id="B35"><label>35</label><mixed-citation>35. Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen 2006; 14: 558–565, doi: 10.1111/j.1743-6109.2006.00155.x.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galkowska</surname><given-names>H</given-names></name><name><surname>Wojewodzka</surname><given-names>U</given-names></name><name><surname>Olszewski</surname><given-names>WL</given-names></name></person-group><article-title>Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers</article-title><source xml:lang="en">Wound Repair Regen</source><year>2006</year><volume>14</volume><fpage>558</fpage><lpage>565,</lpage></element-citation></ref><ref id="B36"><label>36</label><mixed-citation>36. Patel S, Maheshwari A, Chandra A. Biomarkers for wound healing and their evaluation. J Wound Care 2016; 25: 46–55, doi: 10.12968/jowc.2016.25.1.46.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Maheshwari</surname><given-names>A</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name></person-group><article-title>Biomarkers for wound healing and their evaluation</article-title><source xml:lang="en">J Wound Care</source><year>2016</year><volume>25</volume><fpage>46</fpage><lpage>55,</lpage></element-citation></ref><ref id="B37"><label>37</label><mixed-citation>37. Wang H, Han X, Wittchen ES, Hartnett ME. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation. Mol Vis 2016; 22: 116–128.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Wittchen</surname><given-names>ES</given-names></name><name><surname>Hartnett</surname><given-names>ME</given-names></name></person-group><article-title>TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation</article-title><source xml:lang="en">Mol Vis</source><year>2016</year><volume>22</volume><fpage>116</fpage><lpage>128</lpage></element-citation></ref><ref id="B38"><label>38</label><mixed-citation>38. Deng J, Zou ZM, Zhou TL, Su YP, Ai GP, Wang JP, et al. Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Neurol Sci 2011; 32: 641–651, doi: 10.1007/s10072-011-0608-2.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>ZM</given-names></name><name><surname>Zhou</surname><given-names>TL</given-names></name><name><surname>Su</surname><given-names>YP</given-names></name><name><surname>Ai</surname><given-names>GP</given-names></name><name><surname>Wang</surname><given-names>JP</given-names></name></person-group><article-title>Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue</article-title><source xml:lang="en">Neurol Sci</source><year>2011</year><volume>32</volume><fpage>641</fpage><lpage>651,</lpage></element-citation></ref><ref id="B39"><label>39</label><mixed-citation>39. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW, et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 2008; 128: 1852–1860, doi: 10.1038/sj.jid.5701232.</mixed-citation><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peranteau</surname><given-names>WH</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Muvarak</surname><given-names>N</given-names></name><name><surname>Badillo</surname><given-names>AT</given-names></name><name><surname>Radu</surname><given-names>A</given-names></name><name><surname>Zoltick</surname><given-names>PW</given-names></name></person-group><article-title>IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation</article-title><source xml:lang="en">J Invest Dermatol</source><year>2008</year><volume>128</volume><fpage>1852</fpage><lpage>1860,</lpage></element-citation></ref></ref-list></back></article>